生物
转录组
基因敲除
CD36
胰岛素抵抗
基因
下调和上调
细胞生物学
转录因子
基因调控网络
脂质代谢
基因表达谱
ATG5型
锚定
胰岛素受体
微阵列分析技术
遗传学
锚蛋白重复序列
小RNA
计算生物学
癌症研究
过氧化物酶体增殖物激活受体
候选基因
胰岛素
生物信息学
基因表达调控
表型
作者
Jicui Chen,Gang Wu,Wei Shi,Xianjun Ma
出处
期刊:Cell Cycle
[Taylor & Francis]
日期:2026-07-26
卷期号:25 (1): 1-27
被引量:1
标识
DOI:10.1080/15384101.2026.2707583
摘要
Insulin resistance (IR) is the core pathological basis of type 2 diabetes mellitus (T2DM). This study aimed to identify core lipid metabolism-ubiquitination-related feature genes in IR. Integrative transcriptomic and functional analysis screened differential genes via multiple machine learning models. Gene set enrichment analysis (GSEA), regulatory network prediction, and immune infiltration analysis were performed. C2C12 IR models were constructed, and ATG5 was knocked down to detect glucose-lipid metabolism, inflammation, and insulin signaling. Results showed that four feature genes were identified: Good genes Ankyrin Repeat And SOCS Box Containing 4 (ASB4)/ Low Density Lipoprotein Receptor (LDLR) and Bad genes ATG5/ CD36 molecule (CD36 blood group) (CD36). They were enriched in metabolism/inflammation pathways consistent with IR phenotypes. Regulatory network analysis predicted potential upstream microRNAs (miRNAs) and transcription factors (TFs) modulating these feature genes. IR/diabetes groups had lower ImmuneScores vs. insulin-sensitive groups. ATG5 was upregulated in IR models. Its knockdown inhibited autophagy, improved glucose and lipid metabolism, decreased inflammatory cytokines, and exerted no influence on cell viability. In conclusion, ASB4, LDLR, ATG5, and CD36 are potential IR biomarkers. ATG5 regulates IR via autophagy, insulin signaling, and metabolism, serving as a therapeutic target for metabolic diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI